Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluation of a portable device for diagnosing dry eye disease

Official title: Telemedicine for Evaluating Dry Eye Disease (DED) Using a Mobile Phone-Attached Portable Automatic Ocular Surface Imaging Device (PAOSID): A Patient-Operated Diagnostic and Continuous Ocular Surface Monitoring (COSM) System

Run by The Eye Hospital of Wenzhou Medical University · NCT06984549 · Data updated 2026-11-12

This study is testing a new portable device to see if it can accurately diagnose dry eye disease compared to traditional eye exams.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorThe Eye Hospital of Wenzhou Medical University
Academic / other
Locations1 site (Wenzhou, Zhejiang)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedOctober 1, 2025
Study endsDecember 1, 2025
Registry record updatedMay 22, 2025
Trial IDNCT06984549 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 and older with a diagnosis of dry eye disease or healthy individuals with no ocular conditions.

Probably not a fit

Patients with other ocular surface disorders or significant vision impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the diagnostic accuracy and grading consistency of a portable automatic ocular surface imaging device (PAOSID) for assessing dry eye disease (DED). Participants, including those diagnosed with DED and healthy volunteers, will undergo conventional clinical imaging and then use the PAOSID device to capture ocular surface images and videos independently. The study aims to compare the results from the PAOSID with traditional slit-lamp examinations to determine its effectiveness in diagnosing DED. The clinical grading of DED severity will follow established criteria, ensuring a comprehensive assessment of the condition.

Why it matters

Potential benefit: If successful, this study could provide a more accessible and efficient method for diagnosing dry eye disease.

How similar studies have gone: Other studies have shown promise in using portable imaging devices for ocular assessments, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants included individuals with dry eye, based on the TFOS DEWS II (The Tear Film and Ocular Surface Society Dry Eye Workshop II) guidelines,(19) as well as relatively healthy individuals with no ocular conditions who voluntarily agreed to participate in the study.
2. Participants, or their companions or caregivers, who are willing and able to use the study smartphone to capture relevant eye images and videos.
3. Aged 18 years or older.
4. Provide informed consent.

Exclusion Criteria:

1. Participants with ocular surface disorders other than DED that may affect the appearance of the ocular surface (e.g., pterygium, keratitis, corneal scarring) or with any organic pathologies impacting vision (e.g., cataracts, glaucoma, retinal diseases).
2. Patients currently wearing scleral lenses or bandage contact lenses.
3. Unable to cooperate with the PAOSID, such as due to a serious mental illness or brain damage causing loss of limb control.
4. Significant changes in the ocular images since diagnosis due to factors such as postdiagnostic treatment.

Eye selection criteria

Where it's running

  • The Eye Hospital, Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.